Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders
Authors:
- 17 October 2024
- journal article
- research article
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 8 (12) , 1634-1650
Abstract
Chimeric antigen receptor (CAR) T cells targeting receptors on tumour cells have had limited success in patients with glioblastoma. Here we report the development and therapeutic performance of CAR constructs leveraging protein binders computationally designed de novo to have high affinity for the epidermal growth factor receptor (EGFR) or the tumour-associated antigen CD276, which are overexpressed in glioblastoma. With respect to T cells with a CAR using an antibody-derived single-chain variable fragment as antigen-binding domain, the designed binders on CAR T cells promoted the proliferation of the cells, the secretion of cytotoxic cytokines and their resistance to cell exhaustion, and improved antitumour performance in vitro and in vivo. Moreover, CARs with the binders exhibited higher surface expression and greater resistance to degradation, as indicated by bulk and single-cell transcriptional profiling of the cells. The de novo design of binding domains for specific tumour antigens may potentiate the antitumour efficacy of CAR T cell therapies for other solid cancers.Keywords
Funding Information
- National Natural Science Foundation of China (82073268, 32150015, 32370989)
This publication has 63 references indexed in Scilit:
- Isoform-specific inhibition of FGFR signaling achieved by a de-novo-designed mini-proteinCell Reports, 2022
- A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapyCell Metabolism, 2022
- Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and diseaseCell Host & Microbe, 2021
- Integrated analysis of multimodal single-cell dataCell, 2021
- Phase I clinical trial of EGFR-specific CAR-T cells generated by the piggyBac transposon system in advanced relapsed/refractory non-small cell lung cancer patientsJournal of Cancer Research and Clinical Oncology, 2021
- Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid TumorsCancer Cell, 2019
- DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest NeighborsCell Systems, 2019
- Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T CellsCancer Cell, 2019
- Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-DependentCell Reports, 2017
- Prokaryotic expression and refolding of EGFR extracellular domain and generation of phage display human scFv against EGFRBiomedicine & Pharmacotherapy, 2013